CytoReason

Tel Aviv, Israel

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

$80.0M raised

Jul 2024

Series B

Top Investors

NVIDIAPfizerThermo Fisher ScientificOurCrowdAsymmetry Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has CytoReason raised?

CytoReason has raised $80.0M in total funding. The most recent round was Series B. The last funding was announced in July 2024.

Who are CytoReason's investors?

CytoReason's investors include NVIDIA, Pfizer, Thermo Fisher Scientific, OurCrowd, Asymmetry Ventures.

Where is CytoReason headquartered?

CytoReason is headquartered in Tel Aviv, Israel.

What does CytoReason do?

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

What stage is CytoReason at?

CytoReason is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 17, 2024.

MLA

"CytoReason — Funding & Investors." VCBacked, July 17, 2024, https://www.vcbacked.co/company/cytoreason. Accessed June 3, 2026.

APA

VCBacked. (2024). CytoReason — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/cytoreason

Wikipedia (cite web)

{{cite web |title=CytoReason — Funding & Investors |url=https://www.vcbacked.co/company/cytoreason |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 17, 2024.